Skip to content

Study · Not a test of the peptide alone · 2001

1 result

[Comparative in vitro study of the effectiveness of various immunomodulating substances in tick-borne encephalitis].

Krylova NV, Leonova GN

Voprosy virusologii1 Jan 2001

PMID11233283 (opens in a new tab)PepBankPUB-11233283

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01LabNot a test of Thymalin aloneIn vitro (cells)Efficacy outcome

    In vitro, thymalin with human leukocytic interferon was among the most effective protocols for protecting lymphocyte receptor expression against TBE virus.

    In plain wordsIn lab tests, thymalin with human leukocytic interferon was among the most effective tested protocols for protecting lymphocyte receptor expression.

    Peptide
    Thymalin
    Outcome
    IncreaseProtection of T lymphocyte receptor expression
    Study

    n: not reported in source

    Lymphocytes exposed to tick-borne encephalitis virus
    Comparator
    Other tested immunomodulator treatment protocols
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymalin and leukinferon in combination with human leukocytic interferon were the most effective within the treatment protocols.
    2 context sentences
    Summary · context
    Suppressing effect of tick-borne encephalitis (TBE) virus on expression of lymphocyte subpopulation receptors has been demonstrated in vitro.
    Summary · context
    Effects of 14 immunomodulators on expression of T lymphocyte receptors under the effect of TBE virus have been compared.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.